Risk Factors Associated with Adverse Outcomes in a Population-based Prospective Cohort Study of People with Their First Diabetic Foot Ulcer
Overview
Affiliations
Aims/hypothesis: The aim of this study was to determine which clinic-based measures of diabetes and foot status at baseline were associated with adverse outcomes 18 months later in people with diabetes presenting with their first foot ulcer.
Subjects And Methods: This was a prospective population-based cohort study of adults with type 1 and type 2 diabetes mellitus presenting with their first foot ulcer (excluding those with severe ischaemia, ankle brachial pressure index <0.5). The main explanatory variables were age, sex, smoking status, ulcer site (dorsal or plantar), size and severity of ulcer, severity of neuropathy, ischaemia, glycosylated haemoglobin, presence of micro- and macrovascular complications, and depression. The main outcomes recorded were death, amputation and recurrence of ulceration, and the time taken for each outcome to occur.
Results: Two hundred fifty-three people were recruited. There were 40 deaths (15.8%), 36 amputations (15.5%), and 99 recurrences (43.2%) at 18 months. Our main findings were that being older [hazard ratio (HR) 1.07, 95% CI 1.04-1.11], having lower glycosylated haemoglobin (HR 0.73, 95% CI 0.56-0.96), moderate ischaemia (HR 2.74, 95% CI 1.46-5.14), and depression (HR 2.51, 95% CI 1.33-4.73) were associated with mortality. Ulcer severity was the only explanatory factor significantly associated with amputation (HR 3.18, 95% CI 1.53-6.59). Microvascular complications were the only explanatory factor associated with recurrent ulceration (HR 3.34, 95% CI 1.17-9.56).
Conclusions/interpretation: Commonly used primary and secondary care clinic-based measures could provide the basis for a risk assessment tool for adverse outcomes following first presentation of diabetic foot ulcers.
Diabetic foot attack: Managing severe sepsis in the diabetic patient.
Balakrishnan K, Selva Raj D, Ghosh S, Robertson G World J Crit Care Med. 2025; 14(1):98419.
PMID: 40060736 PMC: 11671845. DOI: 10.5492/wjccm.v14.i1.98419.
The Burden of Diabetic Foot Ulcers in Urban India: A Community Healthcare Setup-Based Study.
Patil P, Mishra S, Gadgil A, Bhandarkar P, Roy N, Dwivedi L Indian J Endocrinol Metab. 2024; 28(5):494-499.
PMID: 39676775 PMC: 11642513. DOI: 10.4103/ijem.ijem_346_22.
Vlacho B, Bundo M, Llussa J, Real J, Mata-Cases M, Cos X Cardiovasc Diabetol. 2024; 23(1):209.
PMID: 38898525 PMC: 11188162. DOI: 10.1186/s12933-024-02303-1.
Hsu C, Lai H, Lin H, Pan S, Cheng N, Chen L Open Forum Infect Dis. 2024; 11(6):ofae276.
PMID: 38868313 PMC: 11167667. DOI: 10.1093/ofid/ofae276.
The Efficacy of Diabetic Foot Treatment in a "TOSF" Pattern: A Five-Year Retrospective Study.
Yan C, Wang S, Yang Y, Zhao L, Zhang J, Wang Y Diabetes Metab Syndr Obes. 2024; 17:1923-1939.
PMID: 38711674 PMC: 11073528. DOI: 10.2147/DMSO.S461112.